77 related articles for article (PubMed ID: 8393381)
21. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation.
Hunter RF; Broadway P; Sun SL; Niell HB; Mauer AM
Cancer Res; 1987 May; 47(10):2737-40. PubMed ID: 3032414
[TBL] [Abstract][Full Text] [Related]
22. A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application.
Charak BS; Areman EM; Dickerson SA; Choudhary GD; Sacher R; Kotula PL; Brown EG; Mazumdar A
Bone Marrow Transplant; 1993 Feb; 11(2):147-54. PubMed ID: 8435664
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
24. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
25. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
Kraeft SK; Sutherland R; Gravelin L; Hu GH; Ferland LH; Richardson P; Elias A; Chen LB
Clin Cancer Res; 2000 Feb; 6(2):434-42. PubMed ID: 10690521
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohammed R
Exp Hematol; 1997 Jun; 25(6):471-7. PubMed ID: 9197323
[TBL] [Abstract][Full Text] [Related]
27. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
28. Sex hormones affect bone marrow dysfunction after trauma and hemorrhagic shock.
Sifri ZC; Cohen D; Ananthakrishnan P; Wang L; Kaiser VL; Mohr AM; Hauser CJ; Rameshwar P; Deitch EA; Livingston DH
Crit Care Med; 2007 Mar; 35(3):864-9. PubMed ID: 17255869
[TBL] [Abstract][Full Text] [Related]
29. Fibroblastic colony-forming units and levels of tumor necrosis factor and prostaglandin E2 in bone marrow cultures from patients with advanced lung carcinoma.
Chasseing NA; Bordenave RH; Bullorsky EO; Diaz NB; Stemmelin GR; Rumi LS
Cancer; 1997 Nov; 80(10):1914-9. PubMed ID: 9366293
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow cryopreservation: improved recovery due to bioantioxidant additives in the freezing solution.
Limaye LS
Stem Cells; 1997; 15(5):353-8. PubMed ID: 9323797
[TBL] [Abstract][Full Text] [Related]
31. Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.
Myklebust AT; Pharo A; Fodstad O
Br J Cancer; 1993 Jun; 67(6):1331-6. PubMed ID: 8390285
[TBL] [Abstract][Full Text] [Related]
32. Assessment of methylprednisolone purging efficacy on Daudi burkitt lymphoma cells from normal bone marrow.
Janakiraman N; Niewenhuis LM
Henry Ford Hosp Med J; 1991; 39(2):117-22. PubMed ID: 1890005
[TBL] [Abstract][Full Text] [Related]
33. Experimental studies of the effects of ZnPcS2P2-based-photodynamic therapy on bone marrow purging.
Huang HF; Chen YZ; Wu Y
Chin Med J (Engl); 2005 Jan; 118(2):105-10. PubMed ID: 15667794
[TBL] [Abstract][Full Text] [Related]
34. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
Chang Q; Harvey K; Akard L; Thompson J; Dugan MJ; English D; Jansen J
Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064
[TBL] [Abstract][Full Text] [Related]
35. Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung.
Pollard EB; Tio F; Myers JW; Clark G; Coltman CA; Von Hoff DD
Cancer Res; 1981 Mar; 41(3):1015-20. PubMed ID: 6257379
[TBL] [Abstract][Full Text] [Related]
36. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
[TBL] [Abstract][Full Text] [Related]
37. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
38. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
[TBL] [Abstract][Full Text] [Related]
40. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
